Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)

McGill University

$100,000.00

Systems analysis of trypanosomatid genomes towards drug target discovery

FY 2008-09

Summary
Trypanosomatids cause serious human as well as animal diseases, with a very high incidence and mortality rate if untreated. They cause African sleeping sickness (and related diseases in animals), Chagas disease and the spectrum of diseases called Leishmaniasis. With a mortality rate of 50,000 individuals per year and loss of 2.1 million disability-adjusted life years (DALYs), leishmaniasis is the second most important parasitic infection after malaria, followed by African Sleeping Sickness with 48,000 deaths per year (1.5 million DALYs per year). Chagas disease also causes 15,000 deaths and loss of 700,000 DALYs annually. There are no vaccines for these pathogens, the drugs are toxic with limited effectiveness, and drug resistance is emerging. An ideal drug target should be present in all disease-causing trypanosomatids, either absent from the mammalian host or sufficiently different from its counterpart in the mammalian host. Trypanosomatids share peculiarities distinguishing them from their human host, providing interesting targets for therapeutics. Although the genome sequences of the most prominent trypanosomatids are available, they are poorly annotated and the functions of most of their genes are unknown, limiting the available drug targets to the subset of genes whose functions are known or can be inferred from homology. This project proposes to expand the functional annotation of the genomes of major trypanosomatid pathogens and to use these annotations together with experimental methods to identify and characterize the essential genes in trypanosomatids that will also provide likely targets for development of drugs against multiple trypanosomatids.
Program
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
182274
Name
Salavati Reza
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Genomics: Systems and computational biology
Projecttitle
Systems analysis of trypanosomatid genomes towards drug target discovery
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Keyworddelim
Biochemistry; Bioinformatics; Functional Genomics; Genomics; Protein-Protein Interaction
Abstract
Trypanosomatids cause serious human as well as animal diseases, with a very high incidence and mortality rate if untreated. They cause African sleeping sickness (and related diseases in animals), Chagas disease and the spectrum of diseases called Leishmaniasis. With a mortality rate of 50,000 individuals per year and loss of 2.1 million disability-adjusted life years (DALYs), leishmaniasis is the second most important parasitic infection after malaria, followed by African Sleeping Sickness with 48,000 deaths per year (1.5 million DALYs per year). Chagas disease also causes 15,000 deaths and loss of 700,000 DALYs annually. There are no vaccines for these pathogens, the drugs are toxic with limited effectiveness, and drug resistance is emerging. An ideal drug target should be present in all disease-causing trypanosomatids, either absent from the mammalian host or sufficiently different from its counterpart in the mammalian host. Trypanosomatids share peculiarities distinguishing them from their human host, providing interesting targets for therapeutics. Although the genome sequences of the most prominent trypanosomatids are available, they are poorly annotated and the functions of most of their genes are unknown, limiting the available drug targets to the subset of genes whose functions are known or can be inferred from homology. This project proposes to expand the functional annotation of the genomes of major trypanosomatid pathogens and to use these annotations together with experimental methods to identify and characterize the essential genes in trypanosomatids that will also provide likely targets for development of drugs against multiple trypanosomatids.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Salavati, Reza
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~